Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Ocugen, Inc. | ocgn-20201231.htm |
| EX-32.1 - EX-32.1 - Ocugen, Inc. | ocgn-20201231x10kxex321.htm |
| EX-31.2 - EX-31.2 - Ocugen, Inc. | ocgn-20201231x10kxex312.htm |
| EX-31.1 - EX-31.1 - Ocugen, Inc. | ocgn-20201231x10kxex311.htm |
| EX-21.1 - EX-21.1 - Ocugen, Inc. | ocgn-20201231x10kxex211.htm |
| EX-10.12 - EX-10.12 - Ocugen, Inc. | ocgn-20201231x10kxex1012.htm |
| EX-10.7 - EX-10.7 - Ocugen, Inc. | ocgn-20201231x10kxex107.htm |
| EX-4.8 - EX-4.8 - Ocugen, Inc. | ocgn-20201231x10kxex48.htm |
| EX-4.1 - EX-4.1 - Ocugen, Inc. | ocgn-20201230x10kxex41.htm |
| EX-3.5 - EX-3.5 - Ocugen, Inc. | ocgn-20201231x10kxex35.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-234127) of Ocugen, Inc.
(2)Registration Statement (Form S-3 No. 333-237456) of Ocugen, Inc.
(3)Registration Statement (Form S-8 No. 333-237454) pertaining to the Ocugen, Inc. 2019 Equity Incentive Plan and the Ocugen, Inc. 2014 Stock Incentive Plan
of our report dated March 19, 2021, with respect to the consolidated financial statements of Ocugen, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 19, 2021